Clinical Trial

Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG

Study acronym: PRECISE-AI
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) strategy improves timely intervention of patients requiring cardiac implantable electronic devices (CIEDs), compared with standard clinical care.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-12; most recent amendment 2025-12-05.
Trial Details
NCT Number NCT07217236
Lead Sponsor National Defense Medical Center, Taiwan
Conditions Artificial Intelligence (AI), Cardiac Implantable Electrical Devices, Conduction Disorder of the Heart
Enrollment 11,492 participants
Start Date 2025-11-01
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-12